FDA Clearance Tracker · P020006-S008
ENTERYX PROCEDURE KIT
Last checked: Nov 20, 2026Latest source record: Jun 2, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Jun 2, 2005
Approved
Time to decision
143 days
Received Jan 10, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020006-S008
- Device name
- ENTERYX PROCEDURE KIT
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlborough, MA
- Received
- Jan 10, 2005
- Decided
- Jun 2, 2005
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P020006
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT BOSTON SCIENTIFIC CORPORATION, WAYNE, NEW JERSEY TO CONDUCT PACKAGING AND LABELING OPERATIONS.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.